Recombinant Urate Oxidase for the Prophylaxis or Treatment of Hyperuricemia in Patients With Leukemia or Lymphoma
Ching‐Hon Pui(St. Jude Children's Research Hospital), Gregory H. Reaman(National Cancer Institute), Caroline A. Hastings(UCSF Benioff Children's Hospital), G Leverger(Sorbonne Université), Gerald M. Woods(Children's Mercy Hospital), Joseph M. Wiley(St. Jude Children's Research Hospital), Bruce M. Camitta(Medical College of Wisconsin), Mary V. Relling(St. Jude Children's Research Hospital), Hazem H. Mahmoud(St. Jude Children's Research Hospital), Susan M. Blaney(Pediatrics and Genetics)
Cited by 367
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Treatment of Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2006|2k
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
|Cancer Cell|2002|1.9k
Acute lymphoblastic leukaemia
|The Lancet|2008|1.6k